Alerts

Fecal preservation by freeze-drying: applications and perspectives

Julie Reygner Targeting Microbiota 2019

Dr. Julie Reygner from Université Paris Descartes - Faculté de Pharmacie, France will join in the Congress and will present her work entitled "Fecal preservation by freeze-drying: applications and perspectives" during the congress.

Short summary: Fecal microbiota transplantation (FMT) has now evolved into an efficient therapeutic for the management of recurrent Clostridium difficile infections (rCDIs) with an efficient cure rate reaching 85-95%. We have previously shown that a freeze-dried formulation allowed to conserve FMT preparation over 12 months improving standardization of the stool preparation procedures, process time and thus facilitating patient access to this treatment. The new goal is to improve of the selection of donors, beyond safety of stool samples, in order to develop a rational selection of FMT donor according to the pathology to be treated.

Dr. Reygner is also Best Shor oral presentation award winner of last year and presented short oral presentation "A new freeze-dried formulation to conserve stools over 12 months for fecal transplantation".

This year, Dr. Reygner join participate as Major speaker and will elobrate more about her study on Fecal preservation, ecal transplantation.

 

For more information: www.microbiota-site.com

Industrial Innovation Award was discerned to Sethic Innovation Lab during Targeting Microbiota 2019

The Industrial Innovation Award was discerned to Sethic Innovation Lab during Targeting Microbiota 2019 Congress.

Sethic Innovation Lab


Scientific Committee awarded Sethic Innovation Lab for their innovating cosmetic ingredient OPTIMEALTH(R), presented as a potent ingredient to prevents and reduce skin infections, inflammation and related disorders such as atopic dermatitis, rosacea, psoriasis, and acne.

SethicInnovation

StehicInnovation 

Media center: 
International Society of Microbiota
Contact: [email protected]
www.microbiota-site.com

Microbiota Dysbiosis is Associated with HPV-Induced Cervical Carcinogenesis

Wojciech Kwasniewski Targeting Microbiota 2019Dr. Wojciech Kwaśniewski will present the findings of the present study on "Microbiota Dysbiosis is Associated with HPV-Induced Cervical Carcinogenesis". 

Short summary of the talk: "Over the last decade, it has been indicated that the development and introduction of molecular-based technology has provided novel information regarding the composition of the vaginal‐cervical flora, as well as the abnormal colonization of the genital tract by pathogens. It has been reported that microbe‐induced inflammation can contribute to cervical cancer by stimulating the production of specific cytokines and chemokines, which promote proliferation and/or inhibit apoptosis. Microbiota have been demonstrated to increase, as well as decrease susceptibility to HPV infection. The findings of the present study demonstrated a possible interaction between bacterial flora and HPV infection, as well as an association between this interaction and clinical cervical neoplasia."

For more information: www.microbiota-site.com

Dialogue between the skin and the microbiota: The immune system is under control

Chantal Pichon Targeting Microbiota 2019 updDr. Chantal Pichon from French National Centre for Scientific Research (CNRS ), France will join the Targeting Microbiota 2019 Congress and present her research work on interaction between Skin and Microbiota during the presentation entitled “Dialogue between the skin and the microbiota: The immune system is under control“.

For more information: www.microbiota-site.com

Microbiota and cancer : between Detection and Prognosis

Romain VILLEGER Targeting Microbiota 2019Dr. Romain Villeger from the University of Clermont Auvergne, France will give a presentation entitled "Microbiota and cancer : between Detection and Prognosis" during the 7th World Congress on Targeting Microbiota scheduled on October 10-11, 2019 at the ParkInn Hotel - Krakow, Poland.

The Scientific comittee asked Dr Villeger to comment the recent paper publish in sciencemag.org in July 05, 2019 concerning Microbial stages of colorectal cancer.

For more information: www.microbiota-site.com

 

 

Submit your questions before September 15, 2019 and WIN…

Submit your questions

Despite the wealth of data typically presented, many questions of the participants remain unanswered, and for many scientists, even those who have been considered as keynote speakers, there is only limited opportunity to interact with colleagues.

To facilitate the scientific discussion and make the conference more interactive, the scientific committee has decided to include a round table discussions that address hot topics, challenges and pressing questions to various areas of Microbiota medicine and research.

All questions will be answered and the most pertinent and critical questions will be awarded with the free registration at the Next Microbiota 2020.

All participants are invited to participate in these discussions by sending their questions and thoughts before the meeting by the September 15, 2019 to microbiota(at)microbiota-site.com

Venue & Hotel Booking

Park Inn Hotel Krakow

Ul. Monte Cassino 2 PL-30337 - Krakow - Poland

Microbiota Congress 2019 Parkinn

Book your room here

Single Room: 115€ by night / Double Room: 125€ by night

Please note that due the limited number of rooms,  we have few negotiated rooms from 9th October to 11 October for 2 nights.

 


Please be careful: if some third-party company contacts you for Hotel booking & Transport and asks about your Credit card information.
Please book your Hotel only using the special link below!
 We do not have any representatives or Travel Agency. If anyone contacts you, it is not related to Targeting Microbiota 2019 Congress.

Special Rate for Room Booking at Park Inn by Radisson Krakow

Park inn krakow room 1 Park inn Krakow room 2

Situated close to the area of tourist attractions, Park Inn By Radisson Krakow features views of Krakow, the Wawel Royal Castle and the Kosciuszko Mound. There is also a brief car trip from the Ogrody Krolewskie na Wawelu and Wawel Cathedral. Targeting Microbiota 2019 Committee offers to the congress attendees a special privileged rate for your booking:

  • Single Room: 115€ by night
  • Double Room: 125€ by night (If you would like to see price for DBL room you have to select 2 person on left side of reservation panel and click search.)
 
These prices include breakfast buffet, Wi-Fi connection and a free access to their modern fitness area. 
 

Online Hotel Booking

Promotional Code: MICROB

Terms & conditions:

All room reservations during the Targeting Microbiota 2019 congress - October 10 - 11, 2019 will be made via dedicated booking link. This link will transfer you to Hotel website, where your reservation should be completed by you. You will have to guarantee the reservation by credit card. Credit card will be fully charged 14 days prior to your arrival. After this date no free cancelation will be possible and all reservations will be fully charged – 115 EUR/night (SGL room) or 125 EUR/night (DBL room). Paid reservation will be kept till 7.00 a.m. next hotel day. Room prices are valid from Oct 10, 2019 till Oct 12, 2019.

Psychotropic Drugs and Microbiota - Important and Little Known Interaction

Dr. Łoniewsk Targeting Microbiota 2019

During the 7th World Congress on Targeting Microbiota scheduled on October 10-11, 2019 at the ParkInn Hotel - Krakow, Poland, Dr. Igor Loniewski from Pomeranian Medical University, Poland will give a presentation entitled "Psychotropic Drugs and Microbiota - Important and Little Known Interaction".

Summary of presentation: "Alterations in intestinal microbiota have been associated with the use of antidepressants. Antidepressants differ in mechanisms of their antibacterial activity; for example, they affect cellular respiration, whereby Monoamine Oxidase Inhibitors (MAOIs) can disturb bacterial cell-wall synthesis. Tricyclic antidepressants (TCAs) inhibit DNA gyrase activity and plasmid DNA replication. Selective serotonin reuptake inhibitors (SSRIs) inhibit bacterial efflux pumps. Escitalopram has also antibacterial activity, moreover it was also shown that a six-week escitalopram treatment in a psychiatric hospital setting resulted in increased alpha biodiversity in fecal microbiota Antipsychotic treatment-related microbiome alterations potentially result in body weight gain and metabolic disturbances. Inflammation and resting metabolic rate suppression seem to play crucial roles in the development of metabolic disorders. However in our study we found that the microbiota of schizophrenia patients is highly individual but can be divided into different taxonomical and functional clusters and it does not change following six weeks of olanzapine therapy. Microbiota did not affect either the weight gain observed in women or the effectiveness of olanzapine therapy."

 

For more information: www.microbiota-site.com

 

Skin microbiota 2019: From basics to applied cosmetics and skin care

Florence ABDALLAH Targeting Microbiota 2019Dr. Florence Abdallah from University Paris-Sud - Inserm, France will chair the session dedicated to Skin and Microbiota.

This session is made up of two parts that aim at outlining major findings of skin microbiota and highlighting the importance of skin microbiota modulation for cosmetic application.

The first part
Skin Microbiota : Recent advances and perspectives

This part consists on giving a general overview of the literature for major understandings of skin microbiota including main findings on microbial community composition and plasticity, the crosstalk with skin immune system in health and disease and the current available tools to study skin microbiome diversity.

The second part
Strategies to modulate and affect skin microbiota in health and diseases?

This part  is dedicated to the different possible mechanisms to modify skin microbiota. Since the microbiota is the era of new revolution for the cosmetics and skin care, various cosmetic products composed of probiotics or prebiotics will be presented and discussed.

Finally, an open discussion, questions marks and perspectives in skin microbiology research in health and in disease, and to promote beauty.

Among other speakers:

Dialogue between the skin and the microbiota: The immune system is under control
Chantal Pichon, French National Centre for Scientific Research, France

Intestinal barrier, gut microbiota and psoriasis
Mariusz Sikora, Medical University of Warsaw, Poland

For more information: www.microbiota-site.com

Carcinogenic microbiota of oral cavity

Tomasz M.Karpinski Targeting Microbiota 2019Prof. Tomasz M. Karpiński, Head of Department of Medical Microbiology of Poznań University of Medical Sciences, Poland will join the Targeting Microbiota 2019 congress and will talk "Carcinogenic microbiota of oral cavity".  

Summary of presentation: "The most known bacterial carcinogen is Helicobacter pylori. Recent research indicates a role of oral microorganisms in cancer development. With oral cancer strongly correlate periopathogens, such as Peptostreptococcus sp., Prevotella sp., Fusobacterium sp., Porphyromonas gingivalis, and Capnocytophaga gingivalis. Many works have also shown that the Fusobacterium nucleatum and Porphyromonas gingivalis play an important role in the development of colorectal and pancreatic cancer. Three mechanisms of action have been suggested in the pathogenesis of cancer by oral microbiota: 1. bacterial stimulation of chronic inflammation, 2. influence on cell proliferation, and 3. production of carcinogenic substances".

For more information: www.microbiota-site.com

Gut bacterial metabolites as markers and mediators of cardiovascular aging

Gut bacterial metabolites as markers and mediators of cardiovascular agingProf. Marcin Ufnal will present a research work entitled "Gut bacterial metabolites as markers and mediators of cardiovascular aging".

The Scientific committee invited Prof. Marcin Ufnal from the Medical University of Warsaw, Poland to give a talk during the  7th World Congress on Targeting Microbiota.

Age is a risk factor of cardiovascular and metabolic diseases. Our study in rats suggests that age affects gut bacteria composition and increases concentration of several bacterial metabolites in blood plasma.

Prof. Ufnal will discuss our findings showing the mechanisms of such increase as well as biological effects of some of the bacterial metabolites.

For more information: www.microbiota-site.com

 

Modulating the microbiota of the hospital environment by probiotic cleaning: impact on infections and antimicrobial resistance

ELISABETTA CASELLI Targeting Microbiota 2019 v1During the 7th World Congress on Targeting Microbiota scheduled on October 10-11, 2019 at the ParkInn Hotel - Krakow, Poland, the Scientific commitee will dedicate a full session related to the Built Environment Microbiome.

Dr. Elisabetta Caselli from the University of Ferrara, Italy will give a presentation entitled "Modulating the microbiota of the hospital environment by probiotic cleaning: impact on infections and antimicrobial resistance".

Dr. Caselli summarizes: "Healthcare–associated infections (HAIs) are a global concern, whose major causes include the persistent microbial contamination of the hospital environment, and the growing antimicrobial-resistance (AMR) of HAI-associated microbes.

The control of contamination has been so far addressed by the use of chemical-based sanitation procedures, which however do not prevent recontamination and can select resistant microbes.

By contrast, a microbial-based sanitation system, inspired by the microbiome balance principles, was shown to induce remodulation of hospital microbiota, obtaining a stable control of bioburden and AMR, associated to a significant reduction of HAIs."

 

For more information: www.microbiota-site.com

International Space Station and hospital environments: Composition and function of microbiomes in confined built environments

Christine Moissl Eichinger Targeting Microbiota 2019
During the 7th World Congress on Targeting Microbiota scheduled on October 10-11, 2019 at the Park Inn Hotel - Krakow, Poland, the Scientific commitee will dedicate a full session related to the Built Environment Microbiome.
Prof. Christine Moissl-Eichinger from Medical University Graz, Austria will present the research work entitled "International Space Station and hospital environments: Composition and function of microbiomes in confined built environments".
 
Prof. Moissl-Eichinger highlights: "Indoor environments, where people spend most of their time, are characterized by a specific microbial community, the indoor microbiome. Most indoor environments are connected to the natural environment, but some habitats are more confined: intensive care units, operating rooms, cleanrooms and the international space station (ISS) are extraordinary living and working areas for humans, with a limited exchange with the environment. All of these man-made confined habitats are microbiologically monitored and controlled. However, these measures might apply constant selective pressures, which support microbes with resistance capacities against chemical and physical stresses and thus might facilitate the rise of survival specialists and multi-resistant strains. In this talk, special characteristics of confined indoor microbiomes will be highlighted, and their specific functions and the consequences thereof will be discussed."

For more information: www.microbiota-site.com

Special session on Built Environment Microbiome

Scientific commitee will dedicate a full session related to the Built Environment Microbiome during the Congress.

Markus Egert Targeting Microbiota 2019During the 7th World Congress on Targeting Microbiota scheduled on October 10-11, 2019 at the Park Inn Hotel - Krakow, Poland, the Scientific commitee will dedicate a full session related to the Built Environment Microbiome.

Prof. Dr. Markus Egert from Furtwangen University, Germany will chair this session.

The International Society of Microbiota (ISM) also decided to discuss the using of Microbiomics for forensic sciences. In particuliar the Forensic human identification with targeted microbiome markers.

For more information: www.microbiota-site.com

microRNA in host-microbiome interaction and probiotics

Prof. Elena M Comelli will talk about "microRNA in host-microbiome interaction and probiotics".

Elena Comelli Targeting Microbiota 2019

Prof. Elena M Comelli from University of Toronto, Canada will join the 7th World Congress on Targeting Microbiota scheduled on October 10-11, 2019 at the Park Inn Hotel - Krakow, Poland. 

Her presentation is one of many presentations which is dedicated for a session related to the Built Environment Microbiome.

The International Society of Microbiota (ISM) also decided to discuss the using of Microbiomics for forensic sciences, in particuliar the Forensic human identification with targeted microbiome markers.

For more information: www.microbiota-site.com

Hyaluronan, a new neuroimmune modulator of the microbiota-immune-gut-axis

Cristina Giaron Targeting Microbiota 2019 updDr. Cristina Giaroni from University of Insubria, Italy will give presentation entitled "Hyaluronan, a new neuroimmune modulator of the microbiota-immune-gut-axis".

Summary of talk: "The gut saprophytic commensal flora has a fundamental role in the modulation of several local functions including regulation of host immune system and defense against pathogenic microorganisms. Alterations in the symbiotic relationship between the microbiota and the enteric microenvironment underlays development of complex gut disorders such as chronic inflammatory disease (IBD). In recent years, we have focused on hyluronan (HA), an unbranched glycosaminoglycan (GAG) component of the extracellular matrix, as a new molecular player involved in neuroadaptive changes of enteric neuronal circuitries in the inflamed gut. The GAG is a key molecule mediating the host immune response to commensal and pathogenic bacteria by binding to toll-like receptors, TLR2 and 4. Since both TLRs have been localized to enteric neurons and may regulate intestinal inflammation by controlling enteric nervous system (ENS) structural and functional integrity, HA represents a potential molecular tool involved in development of myenteric neural plasticity by tuning adaptive signals at the intersection between the microbiota-innate immunity axis and ENS. This hypothesis is innovative and opens new scenarios in the study of the molecular mechanism involved in the onset and severity of bowel diseases as well as for the development of new therapeutic agents for the treatment of diseases with clinical and social impact, all with underlying derangements of the microbiota-immune-gut axis, such as IBD."

All results and perspectives will be highlighted during the 7th World Congress on Targeting Microbiota whcih will be organized in Park Inn Hotel - Krakow, Poland, on October 10 - 11, 2019.

For more information: www.microbiota-site.com

Gut microbiota and graft-versus-host disease in patients after bone marrow transplantation. FMT as a prevention or treatment?

Jarosław Bilinski Targeting Microbiota 2019

Dr. Jaroslaw Bilinski from Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Poland will join the 7th World Congress of Targeting Microbiota which will be held in Krakow, Poland on October 10-11, 2019.
 
During the meeting Dr. Bilinski will give a presentation entitled "Gut microbiota and graft-versus-host disease in patients after bone marrow transplantation. FMT as a prevention or treatment?".
 
Gut dysbiosis is considered as trigger or cause of many diseases including graft-versus-host disease (GvHD), a life threatening complication that occurs after allogeneic hematopoietic cell transplantation (alloHCT) caused by an allogeneic attack of donor T cells against recipient tissues. Gut GvHD is the most difficult to treat and linked with high mortality. There are novel insights to immune system interplaying with microbiota which we may use and try to modulate microbiota to prevent or treat GvHD. The question is when and what to do, as the process of immune stimulation is very fluent.

For more information: www.microbiota-site.com

Metabolic and Metagenomic Consequences of E. coli Infections

Matteo SERINO Targeting Microbiota 2019The Scientific Committee of Targeting Microbiota 2019 Congress invited Dr. Matteo Serino from Inserm and Digestive Health Research Institute, France.

Dr. Serino will give a presentation entitled "Metabolic and Metagenomic Consequences of E. coli Infections".

Summary of Presentation: A dietary fat enrichment is among the strongest factors impacting on gut microbiota on a both structural and functional level, as well known as inducer of metabolic diseases such as obesity, type 2 diabetes and hepatopathology. Interestingly, an alimentary switch towards the high-fat content has been also shown  capable of favouring the colonisation of the intestine by enterobacteria. Among the latters are pro-inflammatory and/or genotoxic E. coli strains. The metabolic consequences of the infections by these bacteria in mice will be discussed in relation to a lean vs. an obese/diabetic host, together with changes in the gut microbiota and microbiome.

For more information: www.microbiota-site.com

 

Risk for Diabetes and Cardiovascular diseases in the Qatari population: can the salivary microbiome predict it?

Souhaila Al Khodor Targeting Microbiota 2019Dr. Souhaila Al Khodor from Sidra Medical and Research Center, Qatar will join the 7th World Congress on Targeting Microbiota and speak about "Risk for Diabetes and Cardiovascular diseases in the Qatari population: can the salivary microbiome predict it?" during the Targeting Microbiota 2019 Congress which will be held in Park Inn Hotel - Krakow, Poland, on October 10 - 11, 2019.

Dr. Al Khodor highligthed: "During the Congress I will discuss whether the salivary microbiome composition can predict whether individuals are predisposed to cardiovascular disease or diabetes."

Cardiovascular diseases (CVD) and diabetes are estimated to account for 69% of death in Qatar. Since saliva is an easily accessible sample, not invasive,  it is usually easy to collect from subjects, hence, we plan to assess whether salivary microbiome can be used as a tool to predict those diseases.

Dr. Al Khodor and her team will calculate the CVD score and record the diabetes status (prediabetic, diabetic or non-diabetic) of the study subjects. Then assess the salivary microbiome composition using 16S rRNA gene sequencing and correlate the microbiome data with the phenotypic and clinical data.

The preliminary data will be presented during Targeting Microbiota 2019 Congress.

 

For more information: www.microbiota-site.com

Brain-Gut-Microbiota Axis in Alzheimer’s Disease

Agata Mulak Targeting Microbiota 2019 updatedProf. Agata Mulak, Associate Professor of Medicine from Wroclaw Medical University, Poland will join the 7th World Congress on Targeting Microbiota which will be organized in Park Inn Hotel - Krakow, Poland, on October 10 - 11, 2019 and speak about her research on "Brain-Gut-Microbiota Axis in Alzheimer’s Disease".

For more information: www.microbiota-site.com

Intestinal barrier, gut microbiota and psoriasis

Mariusz Sikora Targeting Microbiota 2019Dr. Mariusz Sikora from Medical University of Warsaw, Poland will join the 7th World Congress on Targeting Microbiota which will be organized in Park Inn Hotel - Krakow, Poland, on October 10 - 11, 2019 and speak about his research on "intestinal barrier, gut microbiota and psoriasis".

For more information: www.microbiota-site.com

Microbiota in the Press & Media

  • 1
  • 2
  • 3
Prev Next